AZNCF
vs
BMY
AZNCF
BMY
Over the past 12 months, AZNCF has significantly outperformed BMY, delivering a return of +24% compared to the BMY's 2% drop.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
AZNCF
BMY
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
AstraZeneca PLC
OTC:AZNCF
|
192.5
USD
|
|||||
|
Bristol-Myers Squibb Co
NYSE:BMY
|
59.08
USD
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
AZNCF, BMY
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
AstraZeneca PLC
Revenue
|
|||||||||||
|
Bristol-Myers Squibb Co
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
AZNCF, BMY
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
AstraZeneca PLC
OTC:AZNCF
|
|||||||||
|
Bristol-Myers Squibb Co
NYSE:BMY
|
|||||||||
Compare company's free cash flow with its competitors.
Gross Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
AstraZeneca PLC | ||||
|
Bristol-Myers Squibb Co | ||||
Operating Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
AstraZeneca PLC | ||||
|
Bristol-Myers Squibb Co | ||||
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
AZNCF, BMY
Performance Gap
AZNCF, BMY
Performance By Year
AZNCF, BMY
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
| US |
|
Eli Lilly and Co
NYSE:LLY
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
|
| UK |
|
GlaxoSmithKline PLC
LSE:GSK
|